MedTrace Logo

Clinical, Virological, Serological and Immunological Characteristics During and Following COVID-19 Hospitalization

NCT05274373 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 47

Last updated 2022-03-10

No results posted yet for this study

Summary

Assessment of the association between the severity of COVID-19 and SARS-CoV-2 NAb titers levels for up to six months following primary infection using a live virus NAb assay. Description of SARS-CoV-2 viral shedding and infectiousness during the first 30 days after infection in a group of unvaccinated hospitalized patients.

Conditions

Sponsors & Collaborators

  • Statens Serum Institut

    collaborator OTHER

  • Rigshospitalet, Denmark

    collaborator OTHER

  • Nordsjaellands Hospital

    lead OTHER

Principal Investigators

  • Zitta Barrella Harboe, MD, PhD · Nordsjaellands Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-24
Primary Completion
2021-05-05
Completion
2023-10-01

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05274373 on ClinicalTrials.gov